Disc Medicine, Inc. (IRON)
61.17
+0.83
(+1.38%)
USD |
NASDAQ |
Mar 06, 15:54
Disc Medicine Cash from Investing (Quarterly) : -222.89M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.802B |
| Boston Scientific Corp. | -512.00M |
| Penumbra, Inc. | -225.65M |
| Rapt Therapeutics, Inc. | 8.466M |
| Amylyx Pharmaceuticals, Inc. | 29.47M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -43.30M |
| Cash from Financing (Quarterly) | 216.68M |
| Free Cash Flow | -181.33M |
| Free Cash Flow Per Share (Quarterly) | -1.158 |
| Free Cash Flow to Equity (Quarterly) | -43.37M |
| Free Cash Flow to Firm (Quarterly) | -42.44M |
| Free Cash Flow Yield | -8.41% |